Journal
CURRENT EYE RESEARCH
Volume 43, Issue 2, Pages 254-261Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/02713683.2017.1383444
Keywords
VKH disease; Treatment regimen; Prognosis factor
Categories
Funding
- Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]
- National Key Clinical Specialties Construction Program of China
- Key Project of Health Bureau of Chongqing [2012-1-003]
- Chongqing Science & Technology Platform and Base Construction Program [cstc2014pt-sy10002]
Ask authors/readers for more resources
Purpose: To investigate the effectiveness, visual outcome, and prognostic factors of Vogt-Koyanagi-Harada (VKH) disease treatment with a reduced dose of corticosteroids combined with immunosuppressive agents. Methods: The clinical characteristics, auxiliary examinations, treatment result, visual outcome, and prognostic factors in VKH patients were analyzed. Results: A total of 998 VKH patients were divided into posterior uveitis group (Group1), anterior uveal involvement group (Group 2), and recurrent granulomatous anterior uveitis group (Group 3). Reduced doses of corticosteroids combined with immunosuppressive agents were used for 1-1.5 years. Uveitis was controlled in 100%, 100%, and 96.8% of these three groups, respectively. Visual improvement and stability was observed in 98.1%, 96.5%, and 88.3%, respectively. Treatment after disease onset, visual acuity at first visit, and 1 month after treatment was positively associated with BCVA at last visit (p < 0.05). Conclusion: A reduced dose of corticosteroids combined with immunosuppressive agents effectively controlled the intraocular inflammation and improved visual acuity in most Chinese VKH patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available